Latest Observability News

GCM Corporation finalises exclusive rights to its Very High Density technology, launches its first commercial heat sink products, and expands global prototyping efforts targeting high-growth sectors including EV infrastructure and data centres.

Southern Palladium reported a doubling in chromite recoveries at its Bengwenyama project, prompting a redesign of the processing plant and pushing the DFS completion to late Q4 2026 amid drilling delays and enhanced metallurgical work.

TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.

Arafura Rare Earths has locked in binding cornerstone equity agreements worth approximately A$230 million, bolstering its path to a final investment decision for the Nolans Project. The company also acquired critical camp infrastructure and is progressing technology development and offtake negotiations amid supportive government frameworks.

PT ANTAM TBK sustained strong operational performance in Q1 2026 with robust gold and nickel sales amid favourable market trends, while pushing forward strategic mineral downstreaming projects including Indonesia's integrated battery ecosystem.

Lake Resources made solid progress on the Exploitation Environmental Impact Assessment for its Kachi Lithium Brine Project, targeting approval in Q3 2026, while maintaining strong liquidity and strategic partnerships.

Cazaly Resources has delivered promising high-grade gold assay results from its latest drilling at the Goongarrie Gold Project, extending mineralisation depth and strike length while initiating a new gravity survey to refine exploration targets.

Amplia Therapeutics reported mature ACCENT trial data showing improved survival and multiple complete responses with narmafotinib, alongside a GMP production milestone and CFO appointment.

Entropy Neurodynamics has reported encouraging early clinical outcomes from its pioneering intravenous psilocin therapy for Binge Eating Disorder, alongside a patent grant that strengthens its intellectual property moat.

New Age Exploration (ASX: NAE) has confirmed high-grade gold mineralisation consistent with Hemi-style intrusion at its Wagyu Gold Project in Western Australia, while also expanding its footprint through the acquisition of the Wallah Silver Project in NSW and progressing drilling in New Zealand.

LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.

Kincora Copper has kicked off a capital-efficient, sole-funded drilling campaign at its 100%-owned Condobolin gold-silver-base metals project in NSW’s Cobar Basin, targeting extensions to the high-grade Meritilga discovery and testing new geochemical and geophysical anomalies.